Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation

Journal of Experimental Medicine

Volumn 199, Issue 8, 2004, Pages 1133-1142

  Zorn, Emmanuel ^a,b,c   Miklos, David B ^a,b,c   Floyd, Blair H ^a   Mattes Ritz, Alex ^a   Guo, Luxuan ^a   Soiffer, Robert J ^a,b,c   Antin, Joseph H ^a,b,c   Ritz, Jerome ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic graft versus host disease; Class II epitope; H Y antigen; Hematopoietic stem cell transplantation; Minor histocompatibility antigen

Indexed keywords

CD4 ANTIGEN; CYCLOPHOSPHAMIDE; DACLIZUMAB; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; HY ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN DBY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; WESTERN BLOTTING; WHOLE BODY RADIATION;

ADULT; AMINO ACID SEQUENCE; B-LYMPHOCYTES; DEAD-BOX RNA HELICASES; EPITOPES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISOANTIBODIES; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; PROTEINS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 2442534666     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031560     Document Type: Article

References (27)

1. Simpson, E., D. Scott, E. James, G. Lombardi, K. Cwynarski, F. Dazzi, M. Millrain, and P.J. Dyson. 2002. Minor H antigens: genes and peptides. Transpl. Immunol. 10:115-123.
2. Falkenburg, J.H., W.A. Marijt, M.H. Heemskerk, and R. Willemze. 2002. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions. Curr. Opin. Hematol. 9:497-502.
3. Riddell, S.R., M. Murata, S. Bryant, and E.H. Warren. 2002. Minor histocompatibility antigens-targets of graft versus leukemia responses. Int. J. Hematol. 76:155-161.
4. Murata, M., E.H. Warren, and S.R. Riddell. 2003. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 197:1279-1289.
5. den Haan, J.M., N.E. Sherman, E. Blokland, E. Huczko, F. Koning, J.W. Drijfhout, J. Skipper, J. Shabanowitz, D.F. Hunt, V.H. Engelhard, et al. 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science. 268:1476-1480.
6. Brickner, A.G., E.H. Warren, J.A. Caldwell, Y. Akatsuka, T.N. Golovina, A.L. Zarling, J. Shabanowitz, L.C. Eisenlohr, D.F. Hunt, V.H. Engelhard, et al. 2001. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J. Exp. Med. 193: 195-206.
7. Spierings, E., A.G. Brickner, J.A. Caldwell, S. Zegveld, N. Tatsis, E. Blokland, J. Pool, R.A. Pierce, S. Mollah, J. Shabanowitz, et al. 2003. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood. 102: 621-629.
8. den Haan, J.M., L.M. Meadows, W. Wang, J. Pool, E. Blokland, T.L. Bishop, C. Reinhardus, J. Shabanowitz, R. Offringa, D.F. Hunt, et al. 1998. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 279:1054-1057.
9. Simpson, E., D. Scott, and P. Chandler. 1997. The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu. Rev. Immunol. 15:39-61.
10. Meadows, L., W. Wang, J.M. den Haan, E. Blokland, C. Reinhardus, J.W. Drijfhout, J. Shabanowitz, R. Pierce, A.I. Agulnik, C.E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity. 6:273-281.
11. Pierce, R.A., E.D. Field, J.M. den Haan, J.A. Caldwell, F.M. White, J.A. Marto, W. Wang, L.M. Frost, E. Blokland, C. Reinhardus, et al. 1999. Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J. Immunol. 163:6360-6364.
12. Vogt, M.H., R.A. de Paus, P.J. Voogt, R. Willemze, and J.H. Falkenburg. 2000. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood. 95:1100-1105.
13. Vogt, M.H., E. Goulmy, F.M. Kloosterboer, E. Blokland, R.A. de Paus, R. Willemze, and J.H. Falkenburg. 2000. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood. 96:3126-3132.
14. Vogt, M.H., J.W. van den Muijsenberg, E. Goulmy, E. Spierings, P. Kluck, M.G. Kester, R.A. van Soest, J.W. Drijfhout, R. Willemze, and J.H. Falkenburg. 2002. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood. 99:3027-3032.
15. Wang, W., L.R. Meadows, J.M. den Haan, N.E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A.I. Agulnik, R.C. Hendrickson, C.E. Bishop, et al. 1995. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 269:1588-1590.
16. Warren, E.H., M.A. Gavin, E. Simpson, P. Chandler, D.C. Page, C. Disteche, K.A. Stankey, P.D. Greenberg, and S.R. Riddell. 2000. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J. Immunol. 164:2807-2814.
17. Spierings, E., C.J. Vermeulen, M.H. Vogt, L.E. Doemer, J.H. Falkenburg, T. Mutis, and E. Goulmy. 2003. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet. 362:610-615.
18. Kollman, C., C.W. Howe, C. Anasetti, J.H. Antin, S.M. Davies, A.H. Filipovich, J. Hegland, N. Kamani, N.A. Kernan, R. King, et al. 2001. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 98:2043-2051.
19. Miklos, D.B., H.T. Kim, E. Zom, E.P. Hochberg, L. Guo, A. Mattes-Ritz, S. Viatte, R.J. Soiffer, J.H. Antin, and J. Ritz. 2004. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in normal female donors. Blood. 103:353-359.
20. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-1118.
21. Currier, J.R., E.G. Kuta, E. Turk, L.B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D.L. Birx, and J.H. Cox. 2002. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods. 260:157-172.
22. Mutis, T., G. Gillespie, E. Schrama, J.H. Falkenburg, P. Moss, and E. Goulmy. 1999. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat. Med. 5:839-842.
23. Scott, D., C. Addey, P. Ellis, E. James, M.J. Mitchell, N. Saut, S. Jurcevic, and E. Simpson. 2000. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity. 12:711-720.
24. Leen, A., P. Meij, I. Redchenko, J. Middeldorp, E. Bloemena, A. Rickinson, and N. Blake. 2001. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. J. Virol. 75:8649-8659.
25. Rammensee, H.G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7:85-96.
26. Delamarre, L., H. Holcombe, and I. Mellman. 2003. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198:111-122.
27. von Muhlen, C.A., E.K. Chan, E. Angles-Cano, M.J. Mamula, I. Garcia-De La Torre, and M.J. Fritzler. 1998. Advances in autoantibodies in SLE. Lupus. 7:507-514.